← Back to context

Comment by terminalshort

16 days ago

OTC vs Rx has massive impact on sales volume which has a massive effect on pricing.

That has nothing to do with drug development expense, which is what you claimed originally.

  • On a unit cost basis, which is the only thing a customer cares about, it absolutely does. You can cover the development costs at a much lower price point if you can sell more units.

    • You're now making an argument about end consumer prices, but this is unrelated to drug development expenses, your original claim.